NO20003211L - Triazinforbindelser for behandling av CNS forstyrrelser - Google Patents
Triazinforbindelser for behandling av CNS forstyrrelserInfo
- Publication number
- NO20003211L NO20003211L NO20003211A NO20003211A NO20003211L NO 20003211 L NO20003211 L NO 20003211L NO 20003211 A NO20003211 A NO 20003211A NO 20003211 A NO20003211 A NO 20003211A NO 20003211 L NO20003211 L NO 20003211L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- cns disorders
- triazine compounds
- triazine
- cns
- Prior art date
Links
- 208000015114 central nervous system disease Diseases 0.000 title 1
- 150000003918 triazines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726987.2A GB9726987D0 (en) | 1997-12-22 | 1997-12-22 | Compounds |
| PCT/EP1998/008273 WO1999032462A1 (en) | 1997-12-22 | 1998-12-18 | Triazine compounds for treatment of cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003211D0 NO20003211D0 (no) | 2000-06-21 |
| NO20003211L true NO20003211L (no) | 2000-08-21 |
Family
ID=10823992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003211A NO20003211L (no) | 1997-12-22 | 2000-06-21 | Triazinforbindelser for behandling av CNS forstyrrelser |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6265405B1 (pt) |
| EP (1) | EP1042304A1 (pt) |
| JP (1) | JP2001526275A (pt) |
| KR (1) | KR20010024800A (pt) |
| CN (1) | CN1284951A (pt) |
| AP (1) | AP2000001846A0 (pt) |
| AR (1) | AR014146A1 (pt) |
| AU (1) | AU753874B2 (pt) |
| BR (1) | BR9814495A (pt) |
| CA (1) | CA2315620A1 (pt) |
| CO (1) | CO5011066A1 (pt) |
| EA (1) | EA200000561A1 (pt) |
| EE (1) | EE200000391A (pt) |
| GB (1) | GB9726987D0 (pt) |
| GT (1) | GT199800203A (pt) |
| HN (1) | HN1998000193A (pt) |
| HR (1) | HRP20000419A2 (pt) |
| HU (1) | HUP0100611A3 (pt) |
| ID (1) | ID25449A (pt) |
| IL (1) | IL136867A0 (pt) |
| IS (1) | IS5542A (pt) |
| JO (1) | JO2065B1 (pt) |
| MA (1) | MA26587A1 (pt) |
| NO (1) | NO20003211L (pt) |
| NZ (1) | NZ505254A (pt) |
| PA (1) | PA8465101A1 (pt) |
| PE (1) | PE20000063A1 (pt) |
| PL (1) | PL341392A1 (pt) |
| SK (1) | SK9592000A3 (pt) |
| SV (1) | SV1998000151A (pt) |
| TR (1) | TR200001970T2 (pt) |
| WO (1) | WO1999032462A1 (pt) |
| YU (1) | YU39600A (pt) |
| ZA (1) | ZA9811725B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0002666D0 (en) | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
| ES2286328T3 (es) * | 2001-12-27 | 2007-12-01 | Ortho-Mcneil Pharmaceutical, Inc. | Aroilpirrolheteroaril y metanoles utiles para tratar transtornos del sistema nervioso central. |
| WO2004012741A1 (en) * | 2002-07-29 | 2004-02-12 | Glaxo Group Limited | Sustained release formulations comprising lamotrigine |
| US20040213842A1 (en) * | 2003-01-30 | 2004-10-28 | Dynogen Pharmaceuticals, Inc. | Methods of treating gastrointestinal tract disorders using sodium channel modulators |
| MY142651A (en) | 2003-03-18 | 2010-12-15 | Merck Sharp & Dohme | Biaryl substituted triazoles as sodium channel blockers |
| DE10332472A1 (de) * | 2003-07-16 | 2005-02-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von Tinnitus |
| BRPI0413982A (pt) * | 2003-08-25 | 2006-11-07 | Newron Pharm Spa | derivados de alfa-aminoamida úteis como agentes anti-inflamatórios |
| US20060115865A1 (en) * | 2004-10-25 | 2006-06-01 | Anlong Ouyang | Lamotrigine analogs |
| GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
| TWI651310B (zh) | 2014-02-20 | 2019-02-21 | 日商日本煙草產業股份有限公司 | 三化合物及其醫藥用途 |
| JP2017039714A (ja) | 2015-08-17 | 2017-02-23 | 日本たばこ産業株式会社 | ヒドロキシトリアジン化合物及びその医薬用途 |
| EP3524605B1 (en) * | 2018-02-13 | 2019-11-27 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | New efficient process for the preparation of sitagliptin |
| CN114796146B (zh) * | 2022-04-28 | 2023-03-28 | 上海奥科达医药科技股份有限公司 | 一种拉莫三嗪的缓释制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3637688A (en) | 1970-01-09 | 1972-01-25 | American Home Prod | 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines |
| IE49823B1 (en) | 1979-06-01 | 1985-12-25 | Wellcome Found | 1,2,4-triazine derivatives,process for preparing such compounds and pharmaceutical compositions containing them |
| EP0021120B1 (en) | 1979-06-01 | 1983-04-06 | The Wellcome Foundation Limited | 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them |
| IT1145308B (it) | 1979-08-16 | 1986-11-05 | Wellcome Found | Composti aromatici sostituiti |
| GB8328757D0 (en) | 1983-10-27 | 1983-11-30 | Wellcome Found | Chemical compounds |
| GB9012316D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012312D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012311D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9203483D0 (en) | 1992-02-19 | 1992-04-08 | Wellcome Found | Anti-inflammatory compounds |
| US5801171A (en) | 1992-06-12 | 1998-09-01 | Glaxo Wellcome Inc | Use of 3, 5-diamino-6-(2,3-dichlorophenyl)-1, 2, 4-triazine isethionate for the treatment and prevention of dependence; tolerance and sensitization of drugs |
| JPH08504798A (ja) | 1992-12-18 | 1996-05-21 | ザ ウエルカム ファウンデーション リミテッド | 酵素阻害薬としての，ピリミジン，ピリジン，プテリジノンおよびインダゾール誘導体 |
| US5866597A (en) | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
| GB9305692D0 (en) | 1993-03-19 | 1993-05-05 | Wellcome Found | Therapeutic triazine compounds and use |
| GB9426448D0 (en) | 1994-12-30 | 1995-03-01 | Wellcome Found | Process |
| FR2741879A1 (fr) | 1995-12-05 | 1997-06-06 | Esteve Labor Dr | Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament |
-
1997
- 1997-12-22 GB GBGB9726987.2A patent/GB9726987D0/en not_active Ceased
-
1998
- 1998-12-18 TR TR2000/01970T patent/TR200001970T2/xx unknown
- 1998-12-18 WO PCT/EP1998/008273 patent/WO1999032462A1/en not_active Ceased
- 1998-12-18 PL PL98341392A patent/PL341392A1/xx unknown
- 1998-12-18 SK SK959-2000A patent/SK9592000A3/sk unknown
- 1998-12-18 CN CN98813745A patent/CN1284951A/zh active Pending
- 1998-12-18 KR KR1020007006947A patent/KR20010024800A/ko not_active Withdrawn
- 1998-12-18 EE EEP200000391A patent/EE200000391A/xx unknown
- 1998-12-18 AU AU24147/99A patent/AU753874B2/en not_active Ceased
- 1998-12-18 CA CA002315620A patent/CA2315620A1/en not_active Abandoned
- 1998-12-18 YU YU39600A patent/YU39600A/sh unknown
- 1998-12-18 IL IL13686798A patent/IL136867A0/xx unknown
- 1998-12-18 NZ NZ505254A patent/NZ505254A/en unknown
- 1998-12-18 AR ARP980106526A patent/AR014146A1/es not_active Application Discontinuation
- 1998-12-18 BR BR9814495-2A patent/BR9814495A/pt not_active IP Right Cessation
- 1998-12-18 EP EP98966635A patent/EP1042304A1/en not_active Withdrawn
- 1998-12-18 EA EA200000561A patent/EA200000561A1/ru unknown
- 1998-12-18 HU HU0100611A patent/HUP0100611A3/hu unknown
- 1998-12-18 ID IDW20001416A patent/ID25449A/id unknown
- 1998-12-18 AP APAP/P/2000/001846A patent/AP2000001846A0/en unknown
- 1998-12-18 JP JP2000525399A patent/JP2001526275A/ja active Pending
- 1998-12-18 HR HR20000419A patent/HRP20000419A2/hr not_active Application Discontinuation
- 1998-12-18 US US09/582,058 patent/US6265405B1/en not_active Expired - Fee Related
- 1998-12-18 SV SV1998000151A patent/SV1998000151A/es unknown
- 1998-12-18 CO CO98075403A patent/CO5011066A1/es unknown
- 1998-12-21 PE PE1998001255A patent/PE20000063A1/es not_active Application Discontinuation
- 1998-12-21 PA PA19988465101A patent/PA8465101A1/es unknown
- 1998-12-21 ZA ZA9811725A patent/ZA9811725B/xx unknown
- 1998-12-21 JO JO19982065A patent/JO2065B1/en active
- 1998-12-22 MA MA25403A patent/MA26587A1/fr unknown
- 1998-12-22 GT GT199800203A patent/GT199800203A/es unknown
-
1999
- 1999-12-21 HN HN1998000193A patent/HN1998000193A/es unknown
-
2000
- 2000-06-20 IS IS5542A patent/IS5542A/is unknown
- 2000-06-21 NO NO20003211A patent/NO20003211L/no unknown
-
2001
- 2001-07-06 US US09/899,198 patent/US6465461B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY117896A (en) | Quinazoline derivatives | |
| GB0111523D0 (en) | Chemical compounds | |
| SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
| MY132671A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
| MX9707980A (es) | Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos. | |
| IL107184A (en) | Heterocyclic ether compounds that enhance cognitive function | |
| GEP20064005B (en) | Use of novel benzoimidazole derivatives as antiproliferative agents | |
| GB9801690D0 (en) | Therapeutic agents | |
| MX9800187A (es) | Compuestos de benzolactama substituidos como antagonistas de la substancia p. | |
| BG106493A (en) | Heteropolycyclic compounds and their use as metabotropic glutamate receptor | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| YU73802A (sh) | Postupak sinteze perindoprila i njegovih farmaceutski prihvatljivih soli | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| NO20003211L (no) | Triazinforbindelser for behandling av CNS forstyrrelser | |
| IL134089A0 (en) | 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring | |
| NO20015172L (no) | 1-metyl-erytromycin-derivater | |
| JO1704B1 (en) | New potent compounds | |
| NO930520L (no) | Bifenyl-substituerte kinolinderivater | |
| BG104575A (en) | Matrix metalloprotease inhibitors | |
| NO981393L (no) | Guanidinoproteasehemmere | |
| WO1999038841A8 (en) | Adamantanecarboximidamide derivatives and their use as nmda antagonists | |
| AU2287499A (en) | Azetidinecarboxamide derivatives for treating cns disorders | |
| AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
| DK1049670T3 (da) | Azetidincarboxamidderivater til behandling af CNS-lidelser | |
| CA2187402A1 (en) | Quinoxaline Derivatives for Treating Tinnitus |